Acurx Pharmaceuticals
ACXP
ACXP
22 hedge funds and large institutions have $679K invested in Acurx Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$125K | |
| 2 | +$56.7K | |
| 3 | +$35.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$17.4K |
| 5 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$4.68K |
Top Sellers
| 1 | -$103K | |
| 2 | -$42.1K | |
| 3 | -$17.2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.26K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$108 |
